Heterocyclic modulators of nuclear receptors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 24, 2004
Grant Date -
Nov 13, 2003
app pub date -
Dec 20, 2002
filing date -
Dec 21, 2001
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Compounds, compositions and methods for modulating the activity of nuclear receptors are provided. In particular, heterocyclic compounds are provided for modulating the activity of farnesoid X receptor (FXR), liver X receptor (LXR) and/or orphan nuclear receptors. In certain embodiments, the compounds are thiazolidinone derivatives.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully